The recent work from Douget et al. showing the beneficial effect of HEI3090, a small molecule positive modulator of mouse P2X7, on anti-tumour responses in combination with immunotherapy [25] suggests that the benefits of positive allosteric modulation of P2X7 may have multiple therapeutic benefits and is an exciting area for future research. Here, P2RX7 is linked to neoplasm.